Suppr超能文献

长时间主动脉阻断期间的心肌保护。血液停搏液与晶体停搏液的比较。

Myocardial protection during prolonged aortic cross-clamping. Comparison of blood and crystalloid cardioplegia.

作者信息

Catinella F P, Cunningham J N, Spencer F C

出版信息

J Thorac Cardiovasc Surg. 1984 Sep;88(3):411-23.

PMID:6471891
Abstract

We compared the ability of blood and crystalloid cardioplegia to protect the myocardium during prolonged arrest. Twelve dogs underwent 180 minutes of continuous arrest. Group I (six dogs) received 750 ml of blood cardioplegic solution (potassium chloride 30 mEq/L) initially and every 30 minutes. Group II (six dogs) received an identical amount of crystalloid cardioplegic solution (potassium chloride 30 mEq, methylprednisolone 1 gm, and 50% dextrose in water 16 ml/L of electrolyte solution). Temperature was 10 degrees C and pH 8.0 in both groups. Studies of myocardial biochemistry, physiology, and ultrastructure were completed before arrest and 30 minutes after normothermic reperfusion. Biopsy specimens for determination of adenosine triphosphate were obtained before, during, and after the arrest interval. Regional myocardial blood flow, total coronary blood flow, and myocardial oxygen consumption were statistically unchanged in Group I (p greater than 0.05). Total coronary blood flow rose 196% +/- 49% in Group II (p less than 0.005), and left ventricular endocardial/epicardial flow ratio fell significantly in this group from 1.51 +/- 0.18 to 0.8 +/- 0.09, p less than 0.01 (mean +/- standard error of the mean. The rise in myocardial oxygen consumption was not significant in this group (34% +/- 36%, p greater than 0.05). Ventricular function and compliance were statistically unchanged in both groups. In Group II, adenosine triphosphate fell 18% +/- 3.4% (p less than 0.005) after 30 minutes of reperfusion; it was unchanged in Group I. Ultrastructural appearance in both groups correlated with these changes. We conclude that blood cardioplegia offers several distinct advantages over crystalloid cardioplegia during prolonged arrest.

摘要

我们比较了血液停搏液和晶体停搏液在长时间心脏停搏期间保护心肌的能力。12只犬接受了180分钟的持续心脏停搏。第一组(6只犬)最初及每30分钟接受750ml血液停搏液(氯化钾30mEq/L)。第二组(6只犬)接受等量的晶体停搏液(氯化钾30mEq、甲基强的松龙1g及50%葡萄糖16ml/L电解质溶液)。两组温度均为10℃,pH值均为8.0。在心脏停搏前及常温再灌注后30分钟完成心肌生物化学、生理学及超微结构研究。在心脏停搏期间及之后获取活检标本以测定三磷酸腺苷。第一组局部心肌血流量、总冠状动脉血流量及心肌氧耗在统计学上无变化(p>0.05)。第二组总冠状动脉血流量增加196%±49%(p<0.005),且该组左心室心内膜/心外膜血流比值从1.51±0.18显著降至0.8±0.09,p<0.01(均值±均值标准误)。该组心肌氧耗增加不显著(34%±36%,p>0.0s)。两组心室功能及顺应性在统计学上无变化。在第二组,再灌注30分钟后三磷酸腺苷下降18%±3.4%(p<0.005);在第一组则无变化。两组的超微结构表现与这些变化相关。我们得出结论,在长时间心脏停搏期间,血液停搏液比晶体停搏液具有若干明显优势。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验